88 related articles for article (PubMed ID: 11420690)
41. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
[TBL] [Abstract][Full Text] [Related]
42. Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model.
Balaji KC; Rao PS; Smith DJ; Louis S; Smith LM; Sherman S; Bacich D; O'Keefe D
Urol Oncol; 2004; 22(4):313-20. PubMed ID: 15283889
[TBL] [Abstract][Full Text] [Related]
43. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME
Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944
[TBL] [Abstract][Full Text] [Related]
44. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
[TBL] [Abstract][Full Text] [Related]
45. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
46. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
[TBL] [Abstract][Full Text] [Related]
47. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.
Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS
Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537
[TBL] [Abstract][Full Text] [Related]
48. [Effects of blocking phospholipase C-gamma1 signaling pathway on proliferation and apoptosis of human colorectal cancer cell line LoVo].
Liu J; Li M; Cheng BL; Zeng WS; Zou ZP; Luo SQ
Ai Zheng; 2007 Sep; 26(9):957-62. PubMed ID: 17927852
[TBL] [Abstract][Full Text] [Related]
49. Selective up-regulation of phospholipase C-beta2 during granulocytic differentiation of normal and leukemic hematopoietic progenitors.
Bertagnolo V; Marchisio M; Pierpaoli S; Colamussi ML; Brugnoli F; Visani G; Zauli G; Capitani S
J Leukoc Biol; 2002 Jun; 71(6):957-65. PubMed ID: 12050180
[TBL] [Abstract][Full Text] [Related]
50. DPM2 regulates biosynthesis of dolichol phosphate-mannose in mammalian cells: correct subcellular localization and stabilization of DPM1, and binding of dolichol phosphate.
Maeda Y; Tomita S; Watanabe R; Ohishi K; Kinoshita T
EMBO J; 1998 Sep; 17(17):4920-9. PubMed ID: 9724629
[TBL] [Abstract][Full Text] [Related]
51. Phospholipase C-gamma modulates epithelial tight junction permeability through hyperphosphorylation of tight junction proteins.
Ward PD; Klein RR; Troutman MD; Desai S; Thakker DR
J Biol Chem; 2002 Sep; 277(38):35760-5. PubMed ID: 12101180
[TBL] [Abstract][Full Text] [Related]
52. Motility is rate-limiting for invasion of bladder carcinoma cell lines.
Kassis J; Radinsky R; Wells A
Int J Biochem Cell Biol; 2002 Jul; 34(7):762-75. PubMed ID: 11950593
[TBL] [Abstract][Full Text] [Related]
53. Two compounds commonly used for phospholipase C inhibition activate the nuclear estrogen receptors.
Cenni B; Picard D
Biochem Biophys Res Commun; 1999 Aug; 261(2):340-4. PubMed ID: 10425187
[TBL] [Abstract][Full Text] [Related]
54. DPM1, the catalytic subunit of dolichol-phosphate mannose synthase, is tethered to and stabilized on the endoplasmic reticulum membrane by DPM3.
Ashida H; Maeda Y; Kinoshita T
J Biol Chem; 2006 Jan; 281(2):896-904. PubMed ID: 16280320
[TBL] [Abstract][Full Text] [Related]
55. [Phospholipase C inhibitor].
Homma Y; Homma M
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1611-7. PubMed ID: 9309162
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of phospholipase C gamma 1 by the prenylated flavonoids from Sophora flavescens.
Lee HS; Ko HR; Ryu SY; Oh WK; Kim BY; Ahn SC; Mheen TI; Ahn JS
Planta Med; 1997 Jun; 63(3):266-8. PubMed ID: 9225612
[TBL] [Abstract][Full Text] [Related]
57. Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
Lee JS; Cho YS; Park EJ; Kim J; Oh WK; Lee HS; Ahn JS
J Nat Prod; 1998 Jul; 61(7):867-71. PubMed ID: 9677265
[TBL] [Abstract][Full Text] [Related]
58. Scientists find new tumor suppressor gene involved in breast, prostate, and other cancers.
J Am Coll Surg; 2001 Jun; 192(6):806. PubMed ID: 11400979
[No Abstract] [Full Text] [Related]
59. OXER1, a G protein-coupled oxoeicosatetraenoid receptor, mediates the survival-promoting effects of arachidonate 5-lipoxygenase in prostate cancer cells.
Sarveswaran S; Ghosh J
Cancer Lett; 2013 Aug; 336(1):185-95. PubMed ID: 23643940
[TBL] [Abstract][Full Text] [Related]
60. Tumor invasion: role of growth factor-induced cell motility.
Wells A
Adv Cancer Res; 2000; 78():31-101. PubMed ID: 10547668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
